Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials
- 31 August 2005
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 87 (2-3) , 161-167
- https://doi.org/10.1016/j.jad.2004.11.011
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose studyDepression and Anxiety, 2004
- P.1.207 Double-blind comparison of escitalopram and venlafaxine XR in the treatment of major depressive disorderEuropean Neuropsychopharmacology, 2003
- Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorderExpert Review of Neurotherapeutics, 2002
- Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed OutpatientsThe Journal of Clinical Psychiatry, 2002
- Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled TrialsCNS Spectrums, 2002
- Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectivesBiological Psychiatry, 1998
- Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxietyBiological Psychiatry, 1998
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959